Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on pharma, health law, and policy issues from August 2020.
Hepatitis C
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy -
Read more: Drug Pricing Controls and the Power of Familiar Ideas Drug Pricing Controls and the Power of Familiar Ideas
By Mark Satta Eight in ten Americans think that prescription drug prices are unreasonable, according to a March 2018 Kaiser poll. That same poll found that more Americans considered passing legislation to lower drug pricing to be a top priority than passing legislation to improve infrastructure or to address the prescription painkiller epidemic, among other…
-
Read more: Gilead Announces Access Program for Hepatitis C Drug Gilead Announces Access Program for Hepatitis C Drug
By Rachel Sachs For all those who are interested in issues of global health, access to medicines, and drug pricing, yesterday Gilead formally announced its access program for enabling many developing countries to purchase its new Hepatitis C drug, Sovaldi, at low prices. This announcement is particularly noteworthy because Sovaldi represents a significant improvement over…